BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21335074)

  • 1. Regulation of proxyphylline's release from silicone rubber matrices by the use of osmotically active excipients and a multi-layer system.
    Soulas DN; Papadokostaki KG
    Int J Pharm; 2011 Apr; 408(1-2):120-9. PubMed ID: 21335074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proxyphylline release kinetics from symmetrical three-layer silicone rubber matrices: effect of different excipients in the outer rate-controlling layers.
    Soulas DN; Sanopoulou M; Papadokostaki KG
    Int J Pharm; 2012 May; 427(2):192-200. PubMed ID: 22330934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
    Liu Q; Fassihi R
    J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
    Jannin V; Pochard E; Chambin O
    Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
    Das MK; Senapati PC
    Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
    Efentakis M; Iliopoyloy A; Siamidi A
    Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of shape factor on the release rate of drugs from lipid matrices.
    Ozdemir N; Karataş A
    Acta Pol Pharm; 1997; 54(5):353-6. PubMed ID: 9584692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.